Session information

ASCO/JSMO Joint Symposium

[AJS1] ASCO/JSMO Joint Symposium　Tumor agnostic vs tumor specific approach toward clinical developments
【SI】【E】

Thu. Feb 17, 2022 9:20 AM - 10:50 AM Room 10 (Royal Room, 1F, The Prince Kyoto Takaragaike)

Chair：Everett Vokes（Department of Medicine, University of Chicago），Takayuki Yoshino（Department of Gastroenterology and Gastrointestinal Oncology, National Cancer Center Hospital East）

+Add all to schedule

[AJS-1] Tumor agnostic drug development: Ready for Prime Time

^○Howard Burris (Sarah Cannon)

[AJS-2] Regulatory considerations for drugs intended to treat patients agnostic of tumor type

^○Steven Lemery (Division of Oncology 3, Office of Oncologic Diseases, Center for Drug Evaluation and Research)

[AJS-3] Organ-specific and tumor-agnostic trials based on SCRUM-Japan MONSTAR-SCREEN

^○Yoshiaki Nakamura (Translational Research Support Section / Department of Gastrointestinal Oncology, National Cancer Center Hospital East)

[AJS-4] Current status and future perspectives of early clinical trial design for tumor agnostic/specific approach

^○Yuki Katsuya (Department of Experimental Therapeutics, National Cancer Center Hospital)

▲